The FAA’s plan to allow pilots to continue flying while taking antidepressant medication has finally generated a decent amount of public comment. As of early last month, there was only one comment from an individual in the rules docket, along with 10 other pieces of information such as the rule change itself and supporting materials.
The FAA on April 2 announ-ced a new policy that will allow pilots taking medication for mild to moderate depression to obtain a special issuance medical certificate. Special issuances are needed for medical conditions that are not allowable for normal first-, second- and third-class medical certification of pilots.
In a new policy statement released on Friday, the FAA said that individuals being treated for “mild to moderate” depression with one of four antidepressant medications–specifically, Prozac, Zoloft, Celexa, Lexapro and their generic equivalents–can be considered for special issuance of a pilot medical certificate.
Prompt access to air ambulances can significantly improve the survival odds of stroke patients, according to a recently released University of Pennsylvania School of Medicine study. The research found that 45 percent of Americans–135 million people–are more than an hour away from primary stroke centers, the facilities best equipped to care for them if they are stricken by the condition. Less than a quarter of U.S.
AAR, an aviation products and services provider, has joined with Cheadle-based Quest International in the UK to develop and distribute Quest’s AirManager, an active air filtration and sterilization system designed to eliminate potentially harmful airborne contaminants. The agreement names AAR an authorized distributor of AirManager.
More than 60 percent of business jet pilots do not use oxygen masks when required to by FAA regulations, according to a survey conducted by corporate pilot Chris Shaver for his master’s thesis at Embry-Riddle Aeronautical University.